Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sangamo Therapeutics
Sort By
Newest First
1 / 1
1 / 1
Cell and Gene Therapy
Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology
Sangamo Therapeutics
PR-M04-19-NI-012
Apr 03, 2019
Clinical Trial
Sangamo Announces Positive Preliminary Data from the Phase 1/2 Alta Study Evaluating SB-525 Gene Therapy for Hemophilia A
Sangamo Therapeutics
PR-M08-18-NI-113
Aug 29, 2018
Oncology
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Sangamo Therapeutics
PR-M02-18-NI-95
Feb 26, 2018
Innovation
Pfizer Collaborates with Gene Editing Company Sangamo Therapeutics on Hemophilia A Treatment
Nigel Walker
Nice Insight
PAO-M05-17-NI-022
May 19, 2017
